810ORANDOMIZED, DOSE-RANGING PHASE II TRIAL OF NIVOLUMAB FOR METASTATIC RENAL CELL CARCINOMA (MRCC).
Publication
, Conference
Motzer, RJ; Rini, BI; McDermott, DF; Redman, B; Kuzel, T; Harrison, MR; Vaishampayan, UN; Drabkin, H; George, S; Logan, T; Margolin, K ...
Published in: Ann Oncol
September 1, 2014
Duke Scholars
Published In
Ann Oncol
DOI
EISSN
1569-8041
Publication Date
September 1, 2014
Volume
25
Issue
suppl_4
Start / End Page
iv281
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Motzer, R. J., Rini, B. I., McDermott, D. F., Redman, B., Kuzel, T., Harrison, M. R., … Hammers, H. (2014). 810ORANDOMIZED, DOSE-RANGING PHASE II TRIAL OF NIVOLUMAB FOR METASTATIC RENAL CELL CARCINOMA (MRCC). In Ann Oncol (Vol. 25, p. iv281). England. https://doi.org/10.1093/annonc/mdu337.3
Motzer, R. J., B. I. Rini, D. F. McDermott, B. Redman, T. Kuzel, M. R. Harrison, U. N. Vaishampayan, et al. “810ORANDOMIZED, DOSE-RANGING PHASE II TRIAL OF NIVOLUMAB FOR METASTATIC RENAL CELL CARCINOMA (MRCC).” In Ann Oncol, 25:iv281, 2014. https://doi.org/10.1093/annonc/mdu337.3.
Motzer RJ, Rini BI, McDermott DF, Redman B, Kuzel T, Harrison MR, et al. 810ORANDOMIZED, DOSE-RANGING PHASE II TRIAL OF NIVOLUMAB FOR METASTATIC RENAL CELL CARCINOMA (MRCC). In: Ann Oncol. 2014. p. iv281.
Motzer, R. J., et al. “810ORANDOMIZED, DOSE-RANGING PHASE II TRIAL OF NIVOLUMAB FOR METASTATIC RENAL CELL CARCINOMA (MRCC).” Ann Oncol, vol. 25, no. suppl_4, 2014, p. iv281. Pubmed, doi:10.1093/annonc/mdu337.3.
Motzer RJ, Rini BI, McDermott DF, Redman B, Kuzel T, Harrison MR, Vaishampayan UN, Drabkin H, George S, Logan T, Margolin K, Plimack ER, Waxman I, Lambert A, Hammers H. 810ORANDOMIZED, DOSE-RANGING PHASE II TRIAL OF NIVOLUMAB FOR METASTATIC RENAL CELL CARCINOMA (MRCC). Ann Oncol. 2014. p. iv281.
Published In
Ann Oncol
DOI
EISSN
1569-8041
Publication Date
September 1, 2014
Volume
25
Issue
suppl_4
Start / End Page
iv281
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis